DK3509638T3 - Præparater med cannabidiolsyreestere og anvendelser deraf - Google Patents
Præparater med cannabidiolsyreestere og anvendelser deraf Download PDFInfo
- Publication number
- DK3509638T3 DK3509638T3 DK18739958.9T DK18739958T DK3509638T3 DK 3509638 T3 DK3509638 T3 DK 3509638T3 DK 18739958 T DK18739958 T DK 18739958T DK 3509638 T3 DK3509638 T3 DK 3509638T3
- Authority
- DK
- Denmark
- Prior art keywords
- acid esters
- preparations containing
- containing cannabidiol
- cannabidiol acid
- preparations
- Prior art date
Links
- WVOLTBSCXRRQFR-DLBZAZTESA-N cannabidiolic acid Chemical class OC1=C(C(O)=O)C(CCCCC)=CC(O)=C1[C@H]1[C@H](C(C)=C)CCC(C)=C1 WVOLTBSCXRRQFR-DLBZAZTESA-N 0.000 title 1
- 238000002360 preparation method Methods 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
- C07C69/76—Esters of carboxylic acids having a carboxyl group bound to a carbon atom of a six-membered aromatic ring
- C07C69/94—Esters of carboxylic acids having a carboxyl group bound to a carbon atom of a six-membered aromatic ring of polycyclic hydroxy carboxylic acids, the hydroxy groups and the carboxyl groups of which are bound to carbon atoms of six-membered aromatic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
- C07C69/02—Esters of acyclic saturated monocarboxylic acids having the carboxyl group bound to an acyclic carbon atom or to hydrogen
- C07C69/12—Acetic acid esters
- C07C69/16—Acetic acid esters of dihydroxylic compounds
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
- C07C69/02—Esters of acyclic saturated monocarboxylic acids having the carboxyl group bound to an acyclic carbon atom or to hydrogen
- C07C69/22—Esters of acyclic saturated monocarboxylic acids having the carboxyl group bound to an acyclic carbon atom or to hydrogen having three or more carbon atoms in the acid moiety
- C07C69/28—Esters of acyclic saturated monocarboxylic acids having the carboxyl group bound to an acyclic carbon atom or to hydrogen having three or more carbon atoms in the acid moiety esterified with dihydroxylic compounds
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Hospice & Palliative Care (AREA)
- Otolaryngology (AREA)
- Pain & Pain Management (AREA)
- Psychiatry (AREA)
- Urology & Nephrology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201762522243P | 2017-06-20 | 2017-06-20 | |
| PCT/IL2018/050678 WO2018235079A1 (en) | 2017-06-20 | 2018-06-20 | Cannabidiolic acid esters compositions and uses thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK3509638T3 true DK3509638T3 (da) | 2022-04-11 |
Family
ID=62875079
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK18739958.9T DK3509638T3 (da) | 2017-06-20 | 2018-06-20 | Præparater med cannabidiolsyreestere og anvendelser deraf |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US11440870B2 (enExample) |
| EP (1) | EP3509638B1 (enExample) |
| JP (1) | JP2020524679A (enExample) |
| CN (1) | CN111032088A (enExample) |
| AU (1) | AU2018287018B2 (enExample) |
| BR (1) | BR112019026916A2 (enExample) |
| CA (1) | CA3067512A1 (enExample) |
| DK (1) | DK3509638T3 (enExample) |
| ES (1) | ES2909350T3 (enExample) |
| MX (1) | MX389847B (enExample) |
| PT (1) | PT3509638T (enExample) |
| WO (1) | WO2018235079A1 (enExample) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US10239808B1 (en) | 2016-12-07 | 2019-03-26 | Canopy Holdings, LLC | Cannabis extracts |
| CA3067512A1 (en) | 2017-06-20 | 2018-12-27 | Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. | Cannabidiolic acid esters compositions and uses thereof |
| EP3745884A1 (en) | 2018-01-31 | 2020-12-09 | Canopy Holdings, Llc | Hemp powder |
| CA3119729A1 (en) | 2018-10-10 | 2020-04-16 | Treehouse Biotech, Inc. | Synthesis of cannabigerol |
| AU2019412836A1 (en) * | 2018-12-25 | 2021-07-01 | Epm (Ip), Inc. | Cannabidiolic acid esters for cosmetic or edible compositions |
| US12403114B2 (en) * | 2019-03-12 | 2025-09-02 | Epm (Ip), Inc. | Cannabinoid acid ester compositions and uses thereof |
| EP4017485A1 (en) | 2019-08-22 | 2022-06-29 | EPM Group, Inc. | Cannabinoid acid ester compositions and uses thereof |
| WO2021137224A1 (en) * | 2020-01-01 | 2021-07-08 | Epm Group, Inc. | Cannabidiolic acid esters for treating muscular dystrophy |
| IL275108A (en) * | 2020-06-03 | 2022-01-01 | Epm Ip Inc | Abnormal acid cannabidiol (abn-cbd) derivatives and their uses |
| US20240000808A1 (en) * | 2020-11-16 | 2024-01-04 | Orcosa Inc. | Improved use of cannabinoids in the treatment of alzheimer's disease |
| US11672761B2 (en) | 2020-11-16 | 2023-06-13 | Orcosa Inc. | Rapidly infusing platform and compositions for therapeutic treatment in humans |
| WO2022137144A1 (en) * | 2020-12-24 | 2022-06-30 | Buzzelet Development And Technologies Ltd. | Compositions comprising cannabinoid acid esters |
| US20230066947A1 (en) * | 2021-08-04 | 2023-03-02 | Max Hammond | Method for the augmentation of substance abuse therapies using cannabinoid formulations |
Family Cites Families (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2318468A1 (fr) * | 1975-07-17 | 1977-02-11 | Jaeger | Dispositif electronique d'enregistrement et de lecture de donnees concernant differents parametres au cours d'un cycle predetermine, fonction de l'un desdits parametres |
| US5342971A (en) | 1992-12-29 | 1994-08-30 | The Australian National University | Process for the preparation of dibenzo[b,d]pyrans |
| ES2224658T3 (es) | 1998-05-04 | 2005-03-01 | The University Of Connecticut | Nuevos canabinoides selectivos hacia el receptor cb2. |
| IL136839A (en) | 2000-06-16 | 2006-12-10 | Yissum Res Dev Co | Pharmaceutical compositions comprising cannabidiol derivatives, and processes for the preparation of same |
| JP2008502690A (ja) | 2004-06-15 | 2008-01-31 | アンドリュー シァン チェン， | リン脂質組成物ならびにその調製方法および使用方法 |
| AU2006297300B2 (en) * | 2005-09-29 | 2012-05-10 | Albany Molecular Research, Inc. | Process for production of delta-9-tetrahydrocannabinol |
| CN101384012B (zh) * | 2008-10-22 | 2012-05-23 | 华为终端有限公司 | 系统端和终端的交互媒体文档更新方法及装置 |
| DE102009019322A1 (de) | 2009-04-30 | 2010-11-11 | The Health Concept Gmbh | Verfahren zur Herstellung von Synthetischen Cannabinoiden |
| GB2478595B (en) | 2010-03-12 | 2018-04-04 | Gw Pharma Ltd | Phytocannabinoids in the treatment of glioma |
| GB2494461A (en) | 2011-09-12 | 2013-03-13 | Gw Pharma Ltd | Phytocannabinoids for use in the treatment of invasive cancers or metastases |
| GB2515312A (en) | 2013-06-19 | 2014-12-24 | Gw Pharma Ltd | The use of phytocannabinoids in the treatment of ovarian carcinoma |
| EP2842933B1 (de) | 2013-09-03 | 2015-07-29 | Symrise AG | Mischungen cannabinoider Verbindungen, deren Herstellung und Verwendung |
| CN106232570B (zh) * | 2014-04-16 | 2018-08-07 | 维瓦赛尔生物技术西班牙有限公司 | 新的大麻二酚醌衍生物 |
| GB2527590A (en) | 2014-06-27 | 2015-12-30 | Otsuka Pharma Co Ltd | Active pharmaceutical ingredient (API) comprising cannabinoids for use in the treatment of cancer |
| GB2531283A (en) | 2014-10-14 | 2016-04-20 | Gw Pharma Ltd | Use of cannabidiols in the treatment of degenerative skeletal muscle diseases |
| EP3061450A1 (de) | 2015-02-26 | 2016-08-31 | Symrise AG | Mischungen cannabinoider Verbindungen, deren Herstellung und Verwendung |
| GB2551987A (en) | 2016-07-01 | 2018-01-10 | Gw Res Ltd | Oral cannabinoid formulations |
| CN106810426B (zh) * | 2016-12-29 | 2020-05-08 | 暨明医药科技（苏州）有限公司 | 一种大麻二酚的合成方法 |
| CA3067512A1 (en) | 2017-06-20 | 2018-12-27 | Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. | Cannabidiolic acid esters compositions and uses thereof |
| WO2019234728A1 (en) | 2018-06-04 | 2019-12-12 | Al&Am Pharmachem Ltd. | Cannabinolic acid derivatives and uses thereof |
-
2018
- 2018-06-20 CA CA3067512A patent/CA3067512A1/en active Pending
- 2018-06-20 ES ES18739958T patent/ES2909350T3/es active Active
- 2018-06-20 JP JP2019570108A patent/JP2020524679A/ja active Pending
- 2018-06-20 CN CN201880041597.0A patent/CN111032088A/zh active Pending
- 2018-06-20 PT PT187399589T patent/PT3509638T/pt unknown
- 2018-06-20 MX MX2019015311A patent/MX389847B/es unknown
- 2018-06-20 WO PCT/IL2018/050678 patent/WO2018235079A1/en not_active Ceased
- 2018-06-20 AU AU2018287018A patent/AU2018287018B2/en active Active
- 2018-06-20 DK DK18739958.9T patent/DK3509638T3/da active
- 2018-06-20 EP EP18739958.9A patent/EP3509638B1/en active Active
- 2018-06-20 BR BR112019026916-9A patent/BR112019026916A2/pt not_active Application Discontinuation
- 2018-06-20 US US16/343,050 patent/US11440870B2/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| ES2909350T3 (es) | 2022-05-06 |
| MX389847B (es) | 2025-03-20 |
| BR112019026916A2 (pt) | 2020-06-30 |
| EP3509638B1 (en) | 2022-01-12 |
| JP2020524679A (ja) | 2020-08-20 |
| EP3509638A1 (en) | 2019-07-17 |
| PT3509638T (pt) | 2022-03-02 |
| CN111032088A (zh) | 2020-04-17 |
| MX2019015311A (es) | 2022-02-02 |
| US11440870B2 (en) | 2022-09-13 |
| AU2018287018B2 (en) | 2022-04-28 |
| WO2018235079A1 (en) | 2018-12-27 |
| US20200115317A1 (en) | 2020-04-16 |
| AU2018287018A1 (en) | 2020-01-30 |
| CA3067512A1 (en) | 2018-12-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK3509638T3 (da) | Præparater med cannabidiolsyreestere og anvendelser deraf | |
| IL268684A (en) | Compositions and methods for immunooncology | |
| IL263676A (en) | Methods and compositions for reducing oxidative stress | |
| DK3478693T3 (da) | Boronsyrederivater og terapeutiske anvendelser deraf | |
| IL256652A (en) | Therapeutic compositions, combinations, and methods of use | |
| IL254959A (en) | Compositions and methods for non-myeloablative conditioning | |
| IL256260B (en) | Treprostinil derivatives and compositions and uses thereof | |
| DK3258942T3 (da) | Kosmetiske og topiske sammensætninger omfattende cannabigerol og cannabidiol | |
| MA44955A (fr) | Anticorps anti-tau et leurs méthodes d'utilisation | |
| DK3357513T3 (da) | Farmaceutisk sammensætning og anvendelse deraf | |
| IL247262B (en) | Cannabinoid compositions and uses | |
| DK3180907T3 (da) | Lægemiddelinformationssystem og fremgangsmåde | |
| DK3354282T3 (da) | Glycan-terapeutiske midler og relaterede fremgangsmåder deraf | |
| SI3274321T1 (sl) | Kanabidiolni izolat iz industrijske konoplje in njegova uporaba v farmacevtskih in/ali kozmetičnih pripravkih | |
| DK3265043T3 (da) | Hjælpemiddel til patienttransport og -træning | |
| HUE053309T2 (hu) | Új sók és gyógyászati készítmények gyulladásos betegségek kezelésére | |
| IL255119B (en) | Therapeutic pooled blood apoptotic cell preparations and uses thereof | |
| DK3412660T3 (da) | Sulfonamidderivat og farmaceutisk sammensætning indeholdende samme | |
| DK3710036T3 (da) | Stable ascorbic acid compositions and methods of using the same | |
| EP3310376A4 (en) | MODIFIED THERAPEUTIC AGENTS AND COMPOSITIONS THEREOF | |
| IL256381A (en) | Cryoprecipitate compositions and methods of preparation thereof | |
| IL247529A0 (en) | Lipoic acid choline ester compositions and methods of use | |
| DK3423076T3 (da) | Topisk cyclosporinholdige formuleringer og anvendelser deraf | |
| DK3380525T3 (da) | Farmaceutiske formuleringer og fremgangsmåder til anvendelse deraf | |
| IL271043A (en) | Compositions and methods for increasing shelf-life of banana |